Skip to content
Open access

Exploring the Inhibitory Effects of Plant Phytoalexins on Escherichia coli: A Genetic Study of Bacterial Resistance Interactions and Gene Expression Associated with Defense Response

Alyaa Neamah Najm al-Saedi Yasemin Khudiar Alghanimi M. Al-shaheen
Jul 2026 · International Journal of Environmental and Biological Sciences · 0 citations

TL;DR

The modulation of resistance-associated gene expression and the emerging correlations between gene expression, biofilm formation, and antibiotic resistance suggest that certain plant phytoalexins, particularly resveratrol, may be promising candidates for treating MDR-EC infections.

Abstract

Background: The emergence of multidrug-resistant Escherichia coli (MDR) is a major public health threat, necessitating the search for novel antibiotic alternatives capable of inhibiting bacterial growth and biofilm formation, as well as modifying resistance mechanisms. The growing interest in plant phytoalexins stems from their diverse spectrum of biological activities and antimicrobial properties. Aim: This study aimed to evaluate the anti-biofilm and antibacterial activity of resveratrol and naringenin against MDR E. coli isolates, their effect on the gene expression levels of marA and acrB, and the relationship between gene expression, biofilm formation, and antibiotic resistance. Materials and Methods: Twenty clinical MDR E. coli isolates were identified using conventional microbiological and biochemical methods, with molecular confirmation where required. Antibacterial activity was assessed using a broth microdilution assay and growth inhibition analysis, while biofilm formation was measured using a crystal violet microplate method. Relative gene expression was assessed using quantitative real-time polymerase chain reaction (qRT-PCR) according to the 2ΔΔCt method, with recA used as a reference gene. Statistical analyses were performed using one-way analysis of variance (ANOVA), the chi- square test, and Pearson's correlation test, with p < 0.05 considered statistically significant. Results: Over 90% of the strains exhibited resistance to ampicillin and cefotaxime, while resistance rates to ciprofloxacin and tetracycline exceeded 70%. Resveratrol exhibited greater antibacterial activity than naringin, with a significant reduction in bacterial growth (OD₆₀₀ = 0.48 ± 0.04 vs. 0.61 ± 0.03) and more potent, concentration-dependent inhibition of biofilm formation (68% vs. 54%). Gene expression analysis: All compounds affected the gene expression of two resistance-associated genes, marA and acrB. A general correlation (χ² = 24.7, p = 0.002) was found between resistance genes and apparent resistance. Correlation analysis also indicated a positive relationship between gene expression and biofilm formation (r = 0.78, p < 0.001) and minimum inhibitory concentration (MIC) values ​​(r = 0.41, p < 0.05). Results: qPCR results showed significant differences in buvirdin biosynthesis genes between non-biofilm-forming and biofilm-forming samples. The expression of two genes was significantly higher in all six bioflux strains compared to non-biofilm-forming samples (p ≤ 0.0388). Conclusion: The results show that both resveratrol and naringenin possess antibacterial and anti-biofilm activity against multidrug-resistant E. coli (MDR-EC), with resveratrol exhibiting superior overall activity. The modulation of resistance-associated gene expression and the emerging correlations between gene expression, biofilm formation, and antibiotic resistance suggest that certain plant phytoalexins, particularly resveratrol, may be promising candidates for treating MDR-EC infections.

Read PDF

Similar papers

Review Open access Aug 2026

Plant-Derived Compounds as Antibiotic Adjuvants Against Drug-Resistant ESKAPE Pathogens: Mechanisms of Action, Synergistic Strategies, and Translational Challenges

Plant-derived antibiotic adjuvants represent a promising strategy to combat multidrug-resistant ESKAPE pathogens, however, greater emphasis on translational research, standardized methodologies, and clinically relevant experimental models is required to facilitate their development toward therapeutic applications.

S. Ruga, Elisa Matarese, F. Castagna et al. · 1 citation
Aug 2026

Evaluation of phytochemical-mediated inhibition of the efflux pump in Pseudomonas aeruginosa PAO1

Results position Salvianolic acid A and the other phytochemicals evaluated here as promising adjuvant candidates for tackling multidrug-resistant Pseudomonas aeruginosa, and warrant their continued investigation as adjunctive therapeutic options alongside conventional antibiotics.

Adarsha Sarmah, Aanand Kumar, Anto Antony Selvaraj et al. · 0 citations
Sep 2026

Isolation of Bacillus subtilis NJ01 and In Silico Evaluation of Its Antimicrobial Metabolites as Potential Inhibitors of the CRN8 Effector Protein of Phytophthora infestans.

Findings suggest that B. subtilis NJ01 possesses promising biocontrol potential and that its reported metabolites warrant further experimental isolation and validation as potential inhibitors of the CRN8 effector protein for the sustainable management of late blight disease.

Nafisa Jakia, Alomgir Hossain, Sohana Mehjabin et al. · 0 citations
Open access Aug 2026

Selected Essential Oils Modulate Ethidium Bromide Accumulation and Exhibit Antibacterial Activity Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae

The increasing prevalence of multidrug-resistant (MDR) Gram-negative bacteria has stimulated the search for plant-derived antimicrobials with alternative modes of action. This study investigated whether chemically distinct essential oils (EOs) differ in their antibacterial effects and their ability to modulate bacteria...

E. Ormai, Nikoletta Szemerédi, B. Kocsis et al. · 0 citations
Review 2025

Synergistic Effects of Selected Herbal Plant Extracts with Antibiotics Against Carbapenem-Resistant Escherichia Coli: A Systematic Review

A holistic overview of the latest research on the antimicrobial activity and synergy of herbal plant extracts on carbapenem-resistant Escherichia coli and multidrug-resistant clinical isolates is discussed, revealing a glimpse of their potential as next-generation antimicrobials.

Sandhya, Amit Kumar, Bijendra Singh et al. · 0 citations
Aug 2026

Dual therapeutic potential of bacteriocin Basin from Bacillus halophilus: attenuation of Enterococcus faecalis virulence gene expression and cytotoxic activity against KB (HeLa-Derived) cells

Bacteriocin Basin exhibits dual bioactivity by attenuating key virulence pathways in E. faecalis and exerting cytotoxic and anti-inflammatory effects on KB (HeLa-derived) cells, providing a preliminary in vitro foundation for exploring the dual bioactivity of bacteriocin Basin.

Sogol Sheikholeslami, Kumarss Amini, Pedram Heidari · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.